Substituted Imidazopyridazines as Lipid Kinase Inhibitors
申请人:Capraro Hans-Georg
公开号:US20100305113A1
公开(公告)日:2010-12-02
The invention relates to novel compounds of the formula I,
as well as other invention embodiments related to these compounds. The compounds are e.g. useful in the treatment of the animal or human body in view of their ability to inhibit protein kinases such as especially PI3 kinase.
SUBSTITUTED IMIDAZOPYRIDAZINES AS PI3K LIPID KINASE INHIBITORS
申请人:Novartis AG
公开号:EP2155753A1
公开(公告)日:2010-02-24
[EN] SUBSTITUTED IMIDAZOPYRIDAZINES AS PI3K LIPID KINASE INHIBITORS<br/>[FR] IMIDAZOPYRIDAZINES SUBSTITUÉES EN TANT QU'INHIBITEURS DE LA LIPIDE KINASE PI3K
申请人:NOVARTIS AG
公开号:WO2008138834A1
公开(公告)日:2008-11-20
[EN] The invention relates to novel compounds of formula (I), as well as other invention embodiments related to these compounds. The compounds are e.g. useful in the treatment of the animal or human body in view of their ability to inhibit protein kinases such as especially PI3 kinase. [FR] L'invention porte sur de nouveaux composés de la formule (1), ainsi que sur d'autres modes de réalisation de l'invention se rapportant à ces composés. Les composés s'utilisent par exemple dans le traitement du corps animal ou humain compte tenu de leur aptitude à inhiber les protéines kinases telles que, notamment, la kinase PI3.